BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

756 related articles for article (PubMed ID: 16458359)

  • 1. Oxidative stress in asthma and COPD: antioxidants as a therapeutic strategy.
    Kirkham P; Rahman I
    Pharmacol Ther; 2006 Aug; 111(2):476-94. PubMed ID: 16458359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative stress in pathogenesis of chronic obstructive pulmonary disease: cellular and molecular mechanisms.
    Rahman I
    Cell Biochem Biophys; 2005; 43(1):167-88. PubMed ID: 16043892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidants/antioxidants and chronic obstructive pulmonary disease: pathogenesis to therapy.
    MacNee W
    Novartis Found Symp; 2001; 234():169-85; discussion 185-8. PubMed ID: 11199095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative stress and gene transcription in asthma and chronic obstructive pulmonary disease: antioxidant therapeutic targets.
    Rahman I
    Curr Drug Targets Inflamm Allergy; 2002 Sep; 1(3):291-315. PubMed ID: 14561194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticosteroids as antioxidants in treatment of asthma and COPD. New application for an old medication?
    Sadowska AM; Klebe B; Germonpré P; De Backer WA
    Steroids; 2007 Jan; 72(1):1-6. PubMed ID: 17145070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Redox modulation of chromatin remodeling: impact on histone acetylation and deacetylation, NF-kappaB and pro-inflammatory gene expression.
    Rahman I; Marwick J; Kirkham P
    Biochem Pharmacol; 2004 Sep; 68(6):1255-67. PubMed ID: 15313424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current perspectives of oxidative stress and its measurement in chronic obstructive pulmonary disease.
    Lin JL; Thomas PS
    COPD; 2010 Aug; 7(4):291-306. PubMed ID: 20673039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update in chronic obstructive pulmonary disease: role of antioxidant and metabolizing gene polymorphisms.
    Lakhdar R; Denden S; Kassab A; Leban N; Knani J; Lefranc G; Miled A; Chibani JB; Khelil AH
    Exp Lung Res; 2011 Aug; 37(6):364-75. PubMed ID: 21721950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative stress and redox regulation of lung inflammation in COPD.
    Rahman I; Adcock IM
    Eur Respir J; 2006 Jul; 28(1):219-42. PubMed ID: 16816350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of steroid activity in chronic inflammation: a novel anti-inflammatory role for curcumin.
    Biswas S; Rahman I
    Mol Nutr Food Res; 2008 Sep; 52(9):987-94. PubMed ID: 18327875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidant--antioxidant imbalance in asthma: scientific evidence, epidemiological data and possible therapeutic options.
    Nadeem A; Masood A; Siddiqui N
    Ther Adv Respir Dis; 2008 Aug; 2(4):215-35. PubMed ID: 19124374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of oxidative stress in the pathogenesis of COPD: implications for therapy.
    Rahman I
    Treat Respir Med; 2005; 4(3):175-200. PubMed ID: 15987234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antioxidant enzymes and melatonin levels in patients with bronchial asthma and chronic obstructive pulmonary disease during stable and exacerbation periods.
    Gumral N; Naziroglu M; Ongel K; Beydilli ED; Ozguner F; Sutcu R; Caliskan S; Akkaya A
    Cell Biochem Funct; 2009 Jul; 27(5):276-83. PubMed ID: 19475625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease.
    MacNee W
    Proc Am Thorac Soc; 2005; 2(1):50-60. PubMed ID: 16113469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L-gamma-Glutamyl-L-cysteinyl-glycine (glutathione; GSH) and GSH-related enzymes in the regulation of pro- and anti-inflammatory cytokines: a signaling transcriptional scenario for redox(y) immunologic sensor(s)?
    Haddad JJ; Harb HL
    Mol Immunol; 2005 May; 42(9):987-1014. PubMed ID: 15829290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exercise-induced systemic effects in muscle-wasted patients with COPD.
    Van Helvoort HA; Heijdra YF; Thijs HM; Viña J; Wanten GJ; Dekhuijzen PN
    Med Sci Sports Exerc; 2006 Sep; 38(9):1543-52. PubMed ID: 16960513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of protein acetylation in inflammatory lung diseases.
    Ito K; Charron CE; Adcock IM
    Pharmacol Ther; 2007 Nov; 116(2):249-65. PubMed ID: 17720252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular basis of chronic inflammation in lung diseases: new therapeutic approach.
    Mroz RM; Noparlik J; Chyczewska E; Braszko JJ; Holownia A
    J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 2):453-60. PubMed ID: 18204158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone deacetylase-2 and airway disease.
    Barnes PJ
    Ther Adv Respir Dis; 2009 Oct; 3(5):235-43. PubMed ID: 19812111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Focus on antioxidant enzymes and antioxidant strategies in smoking related airway diseases.
    Kinnula VL
    Thorax; 2005 Aug; 60(8):693-700. PubMed ID: 16061713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.